Pages that link to "Q51751068"
Jump to navigation
Jump to search
The following pages link to HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial (Q51751068):
Displaying 50 items.
- Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patients (Q21284707) (← links)
- Molecular heterogeneity in breast cancer: State of the science and implications for patient care (Q26738574) (← links)
- Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells (Q26748850) (← links)
- Characterization of DNA Methylation in Circulating Tumor Cells (Q26778427) (← links)
- Single-cell analyses of circulating tumor cells (Q26778816) (← links)
- Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials (Q26827936) (← links)
- Minimal residual disease and circulating tumor cells in breast cancer (Q27010152) (← links)
- The promise of circulating tumor cell analysis in cancer management (Q27022113) (← links)
- Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research (Q27024191) (← links)
- Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection (Q27320919) (← links)
- Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack (Q28067549) (← links)
- Potential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current Evidence (Q28075850) (← links)
- Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines (Q28483475) (← links)
- 'Omic approaches to preventing or managing metastatic breast cancer (Q28730572) (← links)
- Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis (Q33559128) (← links)
- Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets (Q33597032) (← links)
- International study on inter-reader variability for circulating tumor cells in breast cancer (Q33738688) (← links)
- The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial (Q33769034) (← links)
- Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer? (Q33820233) (← links)
- Single-Cell Analysis of Circulating Tumor Cells as a Window into Tumor Heterogeneity (Q33883227) (← links)
- Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer. (Q33917455) (← links)
- Circulating tumor cells predict survival in early average-to-high risk breast cancer patients (Q33958981) (← links)
- Circulating tumor cells in non-metastatic triple-negative breast cancer (Q34111867) (← links)
- Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients (Q34485182) (← links)
- Molecular profiling of single circulating tumor cells with diagnostic intention (Q34542660) (← links)
- Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker (Q34687153) (← links)
- Detection of HER2 amplification in circulating free DNA in patients with breast cancer. (Q34806810) (← links)
- May CTC technologies promote better cancer management? (Q35016353) (← links)
- Gene signatures of breast cancer progression and metastasis. (Q35029477) (← links)
- Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis (Q35053624) (← links)
- Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network (Q35054455) (← links)
- Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticity (Q35124176) (← links)
- Breast Cancer Update 2014 - Focus on the Patient and the Tumour (Q35180940) (← links)
- Prognostic Relevance of Circulating Tumor Cells in Molecular Subtypes of Breast Cancer (Q35427994) (← links)
- A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation (Q35538013) (← links)
- Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment (Q35558126) (← links)
- Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer (Q35608684) (← links)
- A novel platform for detection of CK and CK- CTCs (Q35612329) (← links)
- The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients (Q35619770) (← links)
- Highly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patients (Q35735913) (← links)
- Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients. (Q35749122) (← links)
- Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients (Q35836555) (← links)
- Clinical relevance and biology of circulating tumor cells (Q35889548) (← links)
- An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients (Q35927942) (← links)
- Role of ErbB Receptors in Cancer Cell Migration and Invasion (Q36311027) (← links)
- Considerations in the development of circulating tumor cell technology for clinical use (Q36338628) (← links)
- Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer Patients (Q36482582) (← links)
- Heterogeneity of ERα and ErbB2 Status in Cell Lines and Circulating Tumor Cells of Metastatic Breast Cancer Patients (Q36525788) (← links)
- High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers (Q36532522) (← links)
- EGFR and HER2 signaling in breast cancer brain metastasis (Q36733618) (← links)